Cargando…
Biomarkers for drug development in propionic and methylmalonic acidemias
There is an unmet need for the development and validation of biomarkers and surrogate endpoints for clinical trials in propionic acidemia (PA) and methylmalonic acidemia (MMA). This review examines the pathophysiology and clinical consequences of PA and MMA that could form the basis for potential bi...
Autores principales: | Longo, Nicola, Sass, Jörn Oliver, Jurecka, Agnieszka, Vockley, Jerry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303879/ https://www.ncbi.nlm.nih.gov/pubmed/35038174 http://dx.doi.org/10.1002/jimd.12478 |
Ejemplares similares
-
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
por: Baumgartner, Matthias R, et al.
Publicado: (2014) -
Clinical Course and Nutritional Management of Propionic and Methylmalonic Acidemias
por: Mobarak, Amira, et al.
Publicado: (2020) -
Propionic and Methylmalonic Acidemias: Initial Clinical and Biochemical Presentation
por: Mobarak, Amira, et al.
Publicado: (2020) -
Neuropsychological endpoints for clinical trials in methylmalonic acidemia and propionic acidemia: A pilot study
por: Chapman, Kimberly A., et al.
Publicado: (2023) -
Natural history of propionic acidemia in the Amish population
por: Ehrenberg, Sarah, et al.
Publicado: (2022)